Since liver plays an important role in drug metabolism and excretion in the body, there is increasing interest in investigation of pharmacokinetics in liver diseases. 1, 2) To predict drug disposition in patients with liver diseases, animal models prepared by treatment with toxic compounds have been used. [3] [4] [5] Carbon tetrachloride (CCl 4 ) has been extensively used for preparing experimental models of liver disease such as hepatic cirrhosis and drug-induced hepatopathy. [6] [7] [8] [9] Previous reports demonstrated that oral and intraperitoneal administration of CCl 4 caused renal damage in rats in addition to damaging the liver. [10] [11] [12] [13] These results indicated that the pharmacokinetic results evaluated with these animal models would be affected by not only hepatic but also renal disorders since kidney also plays a significant role in drug excretion. Recently, we attempted CCl 4 targeting to the liver in order to prepare rat models in which only the liver is significantly damaged. 12) By means of several biochemical and physiological parameters, it was shown that the liver was impaired without producing renal damage when CCl 4 was applied to the rat liver surface.
The purpose of the present study was to examine drug disposition in our developed rat model. For this study, we selected phenol red, a hydrophilic dye, as the model drug. This compound has been clinically used for renal function test in humans, 14) and it is excreted into bile and urine as a free form or conjugative metabolite (glucuronic acid conjugate) in rats. 15) After application of CCl 4 to the rat liver surface, phenol red was injected intravenously and its pharmacokinetics was evaluated. Effects of liver surface application of CCl 4 on the pharmacokinetics of phenol red were compared with those of oral and intraperitoneal treatments with CCl 4 .
MATERIALS AND METHODS

Materials
CCl 4 , olive oil and phenol red were obtained from Nacalai Tesque, Inc. (Kyoto, Japan). All other chemicals were commercial products of reagent grade.
Animals Male Wistar rats (250-290 g) were housed in cages in an air-conditioned room and maintained on a standard laboratory diet (MF, Oriental Yeast Co., Ltd., Tokyo, Japan) and water ad libitum. All experiments in the present study conformed to the Guidelines for Animal Experimentation in Nagasaki University.
Liver Surface Application (LSA) Rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and a midline incision about 3 cm in length was made in the abdomen. A cylindrical glass diffusion cell (i.d. 1.8 cm, area 2.54 cm 2 ) was attached to the liver surface with a thin film of surgical adhesive (Aron Alpha, Sankyo Co., Ltd., Tokyo). 12) One milliliter of CCl 4 (LSA group) was added directly to the diffusion cell, and treatment was continued for 2 h. The incision was sutured, and rats were housed in cages in an air-conditioned room with standard rat chow and water ad libitum. p.o. and i.p. Treatments Rats were anesthetized with sodium pentobarbital, and CCl 4 (100 ml) in olive oil was administered orally or intraperitoneally.
Pharmacokinetics of Phenol Red Twenty-four hours after administration of CCl 4 , the femoral artery of rats was cannulated with a polyethylene tube (i. . The body temperature of the rats was kept at 37°C by a heat lamp during the experiment. Phenol red solution was prepared in isotonic phosphate buffer (pH 7.4) to yield a concentration of 10 mg/ml, and 0.1 ml of the solution was injected into the jugular vein. Blood samples were collected at selected times after dosing from the heparinized cannula inserted into the femoral artery over a 6 h period and centrifuged at 15000 rpm for 5 min Animal models prepared by treatment with carbon tetrachloride (CCl 4 ) have been used to examine drug disposition in hepatic disorder. However, previous studies demonstrated that systemic administration of CCl 4 impaired not only hepatic but also renal function. We recently reported that application of CCl 4 to the rat liver surface produced hepatic damage without impairing renal function. In the present study, we examined the pharmacokinetics of phenol red in our developed rat model. The rats treated with CCl 4 by liver surface application exhibited decreases in the biliary clearance of phenol red in comparison with normal rats from 0.54؎0.03 to 0.31؎0.06 ml/min, suggesting hepatic damage. In these rats, the renal clearance of phenol red did not decrease (0.50؎0. 16 (Type M-15-3, Sakuma, Tokyo). Bile samples were collected at appropriate time intervals for 6 h. At 6 h postinjection, urine was collected from the bladder directly by syringe. The concentrations of free phenol red in plasma, bile, and urine were determined spectrophotometrically at 560 nm after dilution with a 1 M NaOH solution. The total concentration of free phenol red and its metabolite was measured in the same manner after they were subjected to acid hydrolysis (2 M HCl at 100°C for 30 min).
15) The concentration of phenol red metabolite was estimated from the difference between these values.
Determination of Pharmacokinetic Parameters The area under the plasma concentration-time curve (AUC p ) was calculated by numeral integration using a linear trapezoidal formula and extrapolation to infinite time based on a monoexponential equation. 16) In the same way, the area under the biliary excretion rate-time curves of free phenol red (AUC b,f ) and its metabolite (AUC b,m ) were determined independently. The biliary clearance (CL b ) and renal clearance (CL r ) were obtained by dividing the total amount of free phenol red excreted into the bile and urine within the collection period (6 h), respectively, by the area under the plasma concentration-time curve up to 6 h after dosing (AUC p,6 h ). The metabolic clearance (CL m ) was also calculated by dividing the total amount of phenol red metabolite excreted into bile and urine by the AUC p,6 h .
Statistical Analysis Statistical analysis was performed by applying the unpaired Student's t-test, with pϽ0.05 considered statistically significant. All results are expressed as mean valuesϮS.E. of six experiments. Figure 1 shows the plasma concentration profiles of free phenol red at a dose of 1 mg after intravenous administration to rats. Phenol red biphasically disappeared from the plasma in all groups. In CCl 4 -treated rats (LSA, p.o. and i.p. groups), the plasma disappearances of phenol red were delayed compared with normal group.
RESULTS
Biliary excretion rate profiles of free phenol red and its metabolite after intravenous administration to rats are given in Fig. 2 . At early time points, the biliary excretion rate of free phenol red in CCl 4 -treated rats (LSA and i.p. groups) decreased as compared with those of normal group. Similar results were obtained in the biliary excretion of phenol red metabolite. Table 1 summarizes the moment parameters for free phenol red and its metabolite after intravenous administration of phenol red. The AUC p values for p.o. and i.p. groups were larger than that for normal group. A similar tendency was observed in LSA group although the difference between LSA and normal group was not statistically significant owing to large fluctuations. In regard to the AUC b,f values, no significant difference was observed between CCl 4 -treated and normal group. The AUC b,m values for CCl 4 -treated groups were significantly lower than that for normal group.
To assess the in vivo behaviors of phenol red in CCl 4 -treated rats, the clearance values were calculated (Table 2) . Both CL b and CL r values for p.o. and i.p. groups were significantly lower than those for normal group. LSA group showed a decrease in CL b value as compared with normal group, 596 Vol. 27, No. 4 
DISCUSSION
Excretion of various amphiphilic compounds occurs in both liver and kidney; their excretion by one route increases when the other is impaired. 17) In regard to phenol red, it was shown that the renal excretion increased to compensate for reduced biliary excretion in the bile duct-ligated rats.
18) Similarly, the compensatory effect on phenol red elimination was observed in the rats treated with CCl 4 by liver surface application in the present study.
On the other hand, oral and intraperitoneal treatments with CCl 4 showed reductions of both biliary and renal clearances of phenol red. This confirms the previous observations that systemic administration of CCl 4 impairs not only hepatic but also renal function. [10] [11] [12] [13] Numerous studies demonstrated that CCl 4 toxicity is dependent on the reduction to trichloromethyl radicals catalyzed by cytochrome P-450 (CYP) such as CYP2E1 and CYP2B. [19] [20] [21] When CCl 4 is administered systemically, the liver is commonly assumed to be the major target organ due to its high content of CYP. However, it was shown that CCl 4 administered systemically in rats was distributed in the kidney at higher concentrations than in the liver. 22) Furthermore, CYP2E1 and CYP2B were reported to exist in the rat tubular cells. 23) Therefore, marked decreases in renal clearance of phenol red are certainly responsible for the impaired tubular secretion by renal distribution of CCl 4 .
The metabolic clearance of phenol red was reduced by systemic administration of CCl 4 . Glucuronidation enzymes, UDP-glucuronosyltransferases are present in many tissues as well as liver in rats. 24) Thus, the metabolism of phenol red in the rats administered systemically with CCl 4 would be affected by the change in not only hepatic but also extrahepatic enzymes.
In conclusion, we examined the pharmacokinetics of phenol red in rats with liver damage prepared by liver surface application of CCl 4 . In these rats, the biliary clearance of phenol red decreased while the renal clearance did not. On the other hand, the rats treated systemically with CCl 4 showed decreases not only in biliary clearance of phenol red but also in the renal clearance. These findings indicate that the model of liver damage prepared by liver surface application of CCl 4 is useful to investigate the effects of hepatic disorder on the pharmacokinetics of drugs. 
